KDR and neoplasm: As shown in Figure 5A, MDA-MB-468/Her2 and MDA-MB-468/VEGFR2 tumor cells were injected s.c. into opposite flanks of the same NCG mice, and T cells were administered once the tumor volume had reached approximately 200 mm3.